AsiaChina· Hepo
First report 30m ago•Last update 30m ago

Concerns over Merck's new saRNA pet vaccine and potential shedding

A new saRNA product for pets by Merck is raising concerns about potential shedding of self-amplifying mRNA to humans and other animals.

Background

The development of mRNA vaccine technology has expanded beyond human medicine to animal health. This trend has prompted discussions among scientists and the public regarding the potential for horizontal gene transfer and environmental impact from novel vaccine platforms.

Quorum · collective opinions

Concerns over Merck's new saRNA pet vaccine and potential shedding

First report 1h agoLast update 1h ago
1 takes▼ 1

iWitness comments

No comments yet — be the first to weigh in.

Concerns over Merck's new saRNA pet vaccine and potential shedding · Quorumz